NDC 0409-0183 – Gemcitabine
Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Intravenous
Product NDC0409-0183
Product details
- Brand name
- Gemcitabine
- Generic name
- Gemcitabine
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA200795
- Marketed since
- July 9, 2013
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Gemcitabine Hydrochloride 38 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0409-0183-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0183-01) / 5.26 mL in 1 VIAL, SINGLE-DOSE | Aug 24, 2011 |
| 0409-0183-25 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0183-25) / 5.26 mL in 1 VIAL, SINGLE-DOSE | Jul 9, 2013 |
Other Gemcitabine products
- 68001-348 Gemcitabine Hydrochloride 100 mg/mL · Injection, Solution · BluePoint Laboratories
- 68001-342 Gemcitabine Hydrochloride 100 mg/mL · Injection, Solution · BluePoint Laboratories
- 68001-359 Gemcitabine Hydrochloride 100 mg/mL · Injection, Solution · BluePoint Laboratories
- 0143-9340 Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9341 Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9342 Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0409-0181 Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-0182 Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-117 Gemcitabine Hydrochloride 38 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 67457-617 Gemcitabine Hydrochloride 1 g/26.3mL · Injection, Solution · Mylan Institutional LLC
- 67457-618 Gemcitabine Hydrochloride 2 g/52.6mL · Injection, Solution · Mylan Institutional LLC
- 67457-616 Gemcitabine Hydrochloride 200 mg/5.26mL · Injection, Solution · Mylan Institutional LLC